SLC22A6 and chronic kidney disease: The aim of this study was to investigate the pharmacokinetic interactions between commonly prescribed drugs in CKD management (ACEIs, ARBs, statins and furosemide) and PBUTs with respect to OAT1-mediated uptake in an in vitro setting.